Drug Resistance in Leishmania Parasites Consequences, Molecular Mechanisms and Possible Treatments /

Drug resistance is a fundamental factor in treatment failure in diseases like leishmaniasis, although additional factors also play a role in this phenomenon. This volume is the second edition of a well-received book that provides a comprehensive update on the pathology of the disease, as well as on...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Ponte-Sucre, Alicia (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Padrón-Nieves, Maritza (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
Έκδοση:2nd ed. 2018.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Prologue
  • Introduction
  • Part I Determinant features in Leishmaniasis
  • Molecular evolution and phylogeny of Leishmania
  • The role of reservoirs: canine Leishmaniasis
  • Epidemiology of Leishmaniasis in the time of drug resistance
  • The role of the immune system in resistance to infection
  • Part II Challenges in the diagnosis, treatment and control of Leishmaniasis in the times of drug resistance
  • Co-infection with HIV
  • Visceral Leishmaniasis
  • Tegumentary Leishmaniasis
  • Antimony accounted sequel post Kala-Azar dermal Leishmaniasis
  • Part III Molecular featrues of drug resistant Leishmania
  • Genetic Expression and drug resistance, the role of proteomics
  • The role of AMC transporters in drug-resistant Leishmania
  • Functional analysis of Leishmania membrane (non AMC) transporters involved in drug resistance
  • Part IV Pharmacology and chemotherapy of Leishmaniasis
  • Classical vs. novel treatment regimens
  • Bioinformatics in Leishmania drug design
  • Leishmanis mitochondria, a druggable organelle
  • P-glycoprotein-like transporters in Leishmania: a search for reversal agents
  • Part V Strategies to circumvent drug resistance in Leishmania
  • The relevance of susceptibility tests, breakpoints and markers
  • The concept of fitness in Leishmania.